Sartorius Stedim Biotech S.A. (SRTOY) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Instruments & Supplies 산업에서 운영. 본사 소재지는 Aubagne, 프랑스. 현재 CEO는 Rene Faber.
SRTOY 을(를) 보유 IPO 날짜 2022-02-09, 9,961 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $210.8B.
Sartorius Stedim Biotech S.A. is a global supplier of instruments, consumables, and services for the biopharmaceutical industry. The company provides a comprehensive portfolio including cell lines, culture media, bioreactors, filtration and purification systems, and single-use bioprocess equipment, as well as data analytics software for optimizing biopharmaceutical development and production. It serves pharmaceutical manufacturers, research laboratories, and producers in the food and chemical industries with solutions spanning cell cultivation, fermentation, purification, and product storage and transportation. Founded in 1870 and headquartered in Aubagne, France, Sartorius Stedim Biotech operates as a subsidiary of Sartorius AG.
